Effect of angiotensin II type 1 receptor antibodies on graft function and survival in paediatric kidney transplant recipients
HLA · 2024
DOI: 10.1111/tan.15649 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2024. Verfasst von R F Kermond und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Nephrology, Women's and Children's Hospital, Adelaide, Australia. Hauptthemen laut MEDLINE: Kidney Transplantation, Receptor, Angiotensin, Type 1, Graft Rejection, Graft Survival. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
HLA donor specific antibodies (DSA) are implicated in antibody‐mediated rejection (AMR), graft dysfunction and failure in kidney transplant (KT) recipients. Non‐HLA antibodies including angiotensin II type 1 receptor (AT1R) may also play a role in AMR, impact graft function and survival. Data is limited in paediatric KT cohorts. We aimed to assess the prevalence and effect of pre‐transplant AT1R antibodies on rejection, graft function and survival in paediatric KT recipients. This was a retrospective cohort study conducted across two paediatric centres including KT recipients with a pre‐transplant AT1R antibody level. Outcomes included rejection, de novo DSA formation, graft function, failure, proteinuria and hypertension. Of 71 individuals, 72% recorded a positive pre‐transplant AT1R Ab level (≥17 U/mL). Over a median follow‐up of 4.7 years, AT1R Ab positivity demonstrated a trend towards increased risk of rejection however was not statistically significant (HR 3.45, 95% CI 0.97–12.35, p ‐value 0.06). Sensitivity analysis with AT1R Ab levels of ≥25 U/mL (HR 2.05 95% CI 0.78–5.39, p ‐value 0.14) and ≥40 U/mL (HR 1.32, CI 95% 0.55–3.17, p ‐value 0.53) validated this. De novo DSA formation occurred more frequently with AT1R Ab positivity (41% vs. 20%, p ‐value 0.9). AT1R Ab was not associated with hypertension, proteinuria, graft failure or dysfunction. In conclusion, this cohort study demonstrated a high prevalence of pre‐transplant AT1R Ab positivity (72%). AT1R Ab positivity demonstrated a trend towards increased risk of rejection and de novo DSA formation however did not meet statistical significance. There was no association between AT1R Ab and hypertension, proteinuria, graft failure or dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatric Nephrology, Women's and Children's Hospital, Adelaide, Australia.
- School of Women's and Children's Health, University of New South Wales, Kensington, Australia.
- Department of Paediatric Nephrology, The Children's Hospital Westmead, Sydney, Australia.
- Centre for Kidney research, Children's Hospital Westmead, Sydney, Australia.
- School of Public Health, Sydney University, Sydney, Australia.
- Department of Paediatric Nephrology, Sydney Children's Hospital, Sydney, Australia.
ORCID-Profile: R F Kermond
Zitieren
APA
Kermond, R. F., Kim, S., Mackie, F., Hahn, D., Carroll, R. P., Sharma, A., & Durkan, A. M. (2024). Effect of angiotensin II type 1 receptor antibodies on graft function and survival in paediatric kidney transplant recipients. HLA. https://doi.org/10.1111/tan.15649
Vancouver
Kermond RF, Kim S, Mackie F, Hahn D, Carroll RP, Sharma A, et al. Effect of angiotensin II type 1 receptor antibodies on graft function and survival in paediatric kidney transplant recipients. HLA. 2024. doi:10.1111/tan.15649
BibTeX
@article{Kermond2024,
author = {Kermond, R F and Kim, S and Mackie, F and Hahn, D and Carroll, R P and Sharma, A and Durkan, A M},
title = {Effect of angiotensin II type 1 receptor antibodies on graft function and survival in paediatric kidney transplant recipients},
journal = {HLA},
year = {2024},
doi = {10.1111/tan.15649}
}
EUVIMED